Completed Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) NCT06272487 Conditions Cardiovascular Diseases, Chronic Disease, Disease Attributes, +13 more Locations Clinical Trial Site — Alexander City, Alabama, United States Clinical Trial Site — Daphne, Alabama, United States Clinical Trial Site — Foley, Alabama, United States Clinical Trial Site — Huntsville, Alabama, United States View all 195 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors NCT02019264 Conditions Body Weight, Cardiovascular Disease, Cardiovascular Diseases, +14 more Locations Advanced Cardiovascular, LLC — Alexander City, Alabama, United States North Alabama Research Center, LLC — Athens, Alabama, United States UAB Medical Center — Birmingham, Alabama, United States Coastal Clinical Research, Inc. — Mobile, Alabama, United States View all 499 locations View more locations Show fewer locations Loading locations... View Trial Details
